
An estimated two million people in the UK are living with undiagnosed chronic obstructive pulmonary disease

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of exacerbation history

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

COPD affects nearly 400 million people globally and is the third leading cause of death worldwide

Around 1.4 million people in the UK are diagnosed with COPD, with two million thought to be undiagnosed

Symptoms of COPD include breathlessness, persistent cough and frequent chest infections

By Emily Morton-West

Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many others are in the pipeline. For older adults,...

The deal includes a PDE3/4 inhibitor in clinical development for COPD

The alliance will centre on Kling’s B cell immortalisation and screening platform Kling-Select

The deal includes a drug approved in the US for chronic obstructive pulmonary disease

More than ten million asthma exacerbations occur in the US every year